Julie Seidel is a Managing Director at Stern IR, based in New York City. Julie joined Stern IR in 2015 as an analyst and has gained IR experience across a wide range of biotechnology companies in various therapeutic areas including oncology, CNS, rare disease, ophthalmology, cardio vascular disease and gene therapy. She is passionate about the ever-changing biotech industry and helping guide companies through their capital raising processes, strategic initiatives and clinical data announcements. Throughout her time at Stern IR, Julie has advised companies through executing the IPO process, raising private rounds and follow-ons, as well as managing corporate collaborations. and maintaining a consistent and effective IR plan for both private and public biotech companies. She particularly loves ad-hoc research projects and creating differentiated messaging for her clients.
Julie graduated from Barnard College with a degree in Psychology. When she’s not working, Julie loves cooking, watching romantic comedies and volunteering and advising for the nonprofit she is involved in for children with Autism Spectrum Disorder.
